绒毛膜羊膜炎相关的严重不良母体结局
基于美国俄亥俄州2006—2015年1393054例活产的回顾性队列研究显示,绒毛膜羊膜炎发生率为1.3%(17430例),其母体ICU入住率(0.5% vs 0.1%,P<.001)和复合不良结局发生率(5.0% vs 1.5%,P<.001)均显著高于无绒毛膜羊膜炎者,校正后风险增加2至3倍。
要点
- 绒毛膜羊膜炎孕妇中每20例即有1例发生复合严重不良母体结局。
- 绒毛膜羊膜炎与母体ICU入住风险增加近3倍相关。
- 排除剖宫产后的敏感性分析仍显示绒毛膜羊膜炎与不良母体结局显著相关。
核心结论
- 绒毛膜羊膜炎妊娠中严重不良结局频率高,每20例中1例受累,母体ICU入住风险较无绒毛膜羊膜炎者增加近3倍。
- 预防和治疗绒毛膜羊膜炎以减少母体风险,可能是降低美国严重母体发病率的重要关注领域。
研究设计与样本
- 研究为基于俄亥俄州2006—2015年全部活产的人群回顾性队列研究。
- 共纳入1393054例活产,其中17430例(1.3%)合并绒毛膜羊膜炎。
- 比较合并与未合并绒毛膜羊膜炎孕妇的母体人口学和产科结局,主要结局为母体ICU入住和复合不良母体结局。
- 采用多因素logistic回归估计绒毛膜羊膜炎与母体不良结局的相对关联。
主要发现
- 合并绒毛膜羊膜炎者母体ICU入住率为0.5%,未合并者为0.1%(P<.001)。
- 合并绒毛膜羊膜炎者复合不良结局发生率为5.0%,未合并者为1.5%(P<.001)。
- 校正共存风险后,绒毛膜羊膜炎与复合不良结局、母体ICU入住、输血、子宫破裂及产后非计划手术的风险增加2至3倍相关。
- 排除剖宫产分娩者的敏感性分析显示,绒毛膜羊膜炎与不良母体结局之间仍存在显著关联。
- 复合不良结局发生率在较早孕周更高,但不良结局的相对风险增加随分娩孕周增加而更明显。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chorioamnionitis complicates 1-5% of all pregnancies and is associated with substantial neonatal morbidity. Prolonged labor and increased use of labor induction may lead to increased rates of chorioamnionitis. OBJECTIVE: We sought to quantify serious adverse maternal outcomes that are associated with chorioamnionitis in a contemporary population of live births in the state of Ohio. STUDY DESIGN: We conducted a population-based retrospective cohort study of all live births in Ohio (2006-2015). Maternal demographic and obstetric outcomes, as reported on the US birth certificate, were compared between women with and without chorioamnionitis. Primary study outcomes were maternal intensive care unit admission and composite adverse maternal outcome (intensive care unit admission, blood product transfusion, unplanned hysterectomy, unplanned operation after delivery, or ruptured uterus). Multivariate logistic regression estimated the relative association of chorioamnionitis with maternal adverse outcomes. RESULTS: Of 1,393,054 live births in Ohio over 10 years, 17,430 live births (1.3%) had chorioamnionitis. Women with chorioamnionitis had significantly higher rates of maternal intensive care unit admission (0.5% vs 0.1%; P<.001) and composite adverse outcome (5.0% vs 1.5%; P<.001) compared with those without chorioamnionitis. Even after adjustment for coexisting risks, chorioamnionitis was associated with 2- to 3-fold increased risk of composite adverse outcome, maternal intensive care unit admission, blood transfusion, ruptured uterus, and unplanned operation after delivery. Sensitivity analysis that excluded women who delivered by cesarean section revealed persistent significant associations between chorioamnionitis and adverse maternal outcomes. The rate of composite adverse outcomes was higher at earlier gestational ages. However, the relative risk increase of adverse outcome was more pronounced with advancing gestational age at delivery. CONCLUSION: The frequency of severe adverse outcomes in pregnancies that are complicated with chorioamnionitis is high, with 1 in every 20 cases affected, and includes an almost 3-fold increased risk for maternal intensive care unit admission compared with patients without chorioamnionitis. Efforts to prevent and treat chorioamnionitis to minimize maternal risk could be an important area of focus in the reduction of the rate of severe maternal morbidity in the United States.
引用
- Perry AK, Rossi RM, DeFranco EA, et al. Severe adverse maternal outcomes associated with chorioamnionitis. Am J Obstet Gynecol MFM. 2019. PMID: 33345791. doi:10.1016/j.ajogmf.2019.06.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。